1-5 of 5
Peter Boross
Close
Sort by
Journal Articles

Preclinical Anti-Tumor Activity of Hexabody-CD38 in Patient-Derived B Cell Lymphoma and Acute Myeloid Leukemia Xenograft Models

Ida H Hiemstra, PhD, Maarten L Janmaat, PhD, Peter Boross, PhD, Jeroen van den Brakel, Wessel ten Hagen, Sanne van Dooremalen, Sieto Bosgra, PhD, Bart ECG De Goeij, PhD, Grietje Andringa, Laurens Kil, PhD, A Kate Sasser, PhD, Tahamtan Ahmadi, MD PhD, David Satijn, PhD, Esther CW Breij, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-140313
Published: 2020
Journal Articles

Towards Restoring Coagulation in Hemophilia By Antibody-Mediated Inhibition of Antithrombin

Peter Boross, PhD, Cafer Yildiz, Kamran Bakhtiari, PhD, Joost C.M. Meijers, Prof, PhD, C. Erik Hack, MD PhD
Journal: Blood
Blood (2015) 126 (23): 550.
https://doi.org/10.1182/blood.V126.23.550.550
Published: 2015
Journal Articles

Daratumumab, a Human CD38 Antibody Induces Apoptosis of Myeloma Tumor Cells Via Fc Receptor-Mediated Crosslinking.

J. H. Marco Jansen, Peter Boross, PhD, Marije B. Overdijk, PhD student, Jeroen J. Lammerts van Bueren, PhD, Paul W.H.I. Parren, PhD, Jeanette H. W. Leusen, PhD
Journal: Blood
Blood (2012) 120 (21): 2974.
https://doi.org/10.1182/blood.V120.21.2974.2974
Published: 2012
Journal Articles

Boosting antibody therapy with complement

Peter Boross, Jeanette H. W. Leusen
Journal: Blood
Blood (2012) 119 (25): 5945–5947.
https://doi.org/10.1182/blood-2012-04-420760
Published: 2012
Journal Articles

Cytokine-induced immune complex binding to the high-affinity IgG receptor, FcγRI, in the presence of monomeric IgG

Cees E. van der Poel, Roos A. Karssemeijer, Peter Boross, Joke A. van der Linden, Miranda Blokland, Jan G. J. van de Winkel, Jeanette H. W. Leusen
Journal: Blood
Blood (2010) 116 (24): 5327–5333.
https://doi.org/10.1182/blood-2010-04-280214
Published: 2010
Includes: Supplemental data